Clinical Trial Update: EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients

View source ↗

Summary

This completed clinical trial evaluated Epstein-Barr virus infections as a risk factor for post-transplant lymphoproliferative disorder in pediatric and adult r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection
• Post-transplant Lymphoproliferative Disorder

Snippet

Sponsor: Klinik für Kinder- und Jugendmedizin | Conditions: Epstein-Barr Virus Infections | Status: COMPLETED